BioPharmSignal logoBioPharmSignal

Biotech News

Transactions of Managers and Closely Associated Persons

Alvotech (ALVO)AlvotechCompany update

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 10,133,333 shares in Alvotech by Celtic Lux Holdings S.a. r.l. (formerly known as Alvogen Lux Holdings S.a. r.l.) at a price of USD 3.75 per share. The date of the transaction was June 16, 2026.

ALVOTECH INVESTOR RELATIONS Benedikt Stefansson, VP alvotech.ir@alvotech.com

Celtic Lux Holdings Managers' Transaction Notification 2026-06-22

Related news

ALVOAlvotech2026-07-03 20:01 EST

Viðskipti stjórnenda og tengdra aðila

ALVOAlvotech2026-06-18 09:51 EST

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

AZNAstraZeneca PLC2016-11-01 15:30 EST

Dealing by Person Closely Associated

View all latest news

Alvotech

Alvotech is a biosimilars company developing and manufacturing lower-cost alternatives to complex biologic medicines.

Recent company news

ALVOAlvotech2026-07-03 20:01 EST

Viðskipti stjórnenda og tengdra aðila

ALVOAlvotech2026-07-03 20:01 EST

Transactions of Managers and Closely Associated Persons

ALVOAlvotech2026-07-01 08:00 EST

Alvotech styrkir lausafjárstöðu sína enn frekar með aðgengi að 75 milljóna dala lánsfjármögnun

ALVOAlvotech2026-07-01 08:00 EST

Alvotech further strengthens liquidity by securing term loan facility of $75 million

ALVOAlvotech2026-06-22 22:48 EST

Viðskipti stjórnenda og tengdra aðila

Stock data

Close
3.08 USD
Market cap
936.14M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States